-
8/10/2019 Adi-Alon
1/20
T M
The 3rdAnnual Life
Science ConferenceFebruary 2001
Biotechnology Strategy ProjectBiotechnology Strategy Project
Realizing Israel PotentialRealizing Israel Potential
Adi AlonMonitor Group
-
8/10/2019 Adi-Alon
2/20
T M
Febtuary 2001
Project Overview
The potential
The challenge and the action plan
AgendaAgenda
-
8/10/2019 Adi-Alon
3/20
T M
Febtuary 2001
Monitor Grou ! "#er#ie$Monitor Grou ! "#er#ie$
The Action Company
Decision
Architects
M2C
Monitor
Clipper
Partners
M.A.S.T.
Maretspace
Center
!"#Commerce$
Corporate
%inance
Monitor
&niversity
Monitor
'nstit(te
Activities
Processes )
Systems
Founded 1983, Cambridge USA
Mix of strategy consulting,investment baning and !rivatee"uity
#ruly global o!erations $ no local!artners%i!s or geogra!%icbarriers
All &rou! com!anies o!eratet%roug% all '( offices globally $including #el Aviv
8)*+ of engagements are re!eatclients
Committed to creating action $ not
re!orts
oring in almost all industrysectors
-eading global ex!erts
-
8/10/2019 Adi-Alon
4/20
T M
Febtuary 2001
Project "#er#ie$ ! %ey IssuesProject "#er#ie$ ! %ey Issues
's there a potential *or +iotechnology ind(stry in 'srael,
'* there is a potential # what sho(ld 'srael do to reali-e it,
-
8/10/2019 Adi-Alon
5/20
T M
Febtuary 2001
A local context thatencourages sustainedinvestment in upgrading
Vigorous competitionamong locally$basedrivals
A critical mass of capable localsuppliers
Clustersinstead of isolated industries
A core group of demandinglocal customers
Unusual local demand ins!eciali.ed segmentsthat
can be served globally Customers whose needs
antici!atethose elsewhere
Factor (input) uantity
Factor "uality Factor s!eciali.ation
/elated and/elated and
Su!!ortingSu!!orting0ndustries0ndustries
emand
Conditions
Factor
Conditions
Context forFirm
Strategyand /ivalry
&overnment&overnment
Co&etiti#eness of 'ations( States( and CitiesCo&etiti#eness of 'ations( States( and Cities
The )ia&ond AroachThe )ia&ond Aroach
-
8/10/2019 Adi-Alon
6/20
T M
Febtuary 2001
Project "#er#ie$ ! %ey Acti#itiesProject "#er#ie$ ! %ey Acti#ities
Israel Research
International
Research
Reco&&endations and Action Plan
Over // interviews # pro*iling the ind(stry and the challenges it
*aces
Developed detailed mapping o* the activities cond(cted in
0iotechnology 0y 'sraeli ind(stry and academia
Collected and analy-ed relevant data to the challenges raised d(ring
'sraeli cl(ster interviews
Cond(cted in depth research o* international 0iotechnology cl(sters
to identi*y development challenges and so(rces o* s(ccess1
Pro*iled glo0al ind(stry trends and mapped them against the cl(ster
activities in 'srael
-
8/10/2019 Adi-Alon
7/20T M
Febtuary 2001
Project Overview
The Potential
The Challenge and the action plan
AgendaAgenda
-
8/10/2019 Adi-Alon
8/20T M
Febtuary 2001
!
"!
#!
$!
%!
&!!
&"!
"!!# "!&!
2roected &ro4t% of &lobal
5iotec%nology Maret 675
$'n
ource Consulting *esources +nc, &--%. 'usiness (!"/"!!!). Frost 0 ullivan . 'iotechnology +ndustry 1rgani2ation
Glo*al Potential ! Strong Gro$th Is +,ectedGlo*al Potential ! Strong Gro$th Is +,ected
in the Biotech Mar-etin the Biotech Mar-et BioTherapeutics Growth driven by:
Imminent patent expirations
Increasing demand
Need for improvement in R! economics
Bioinformatics, pharmocogenomics
Agricultural Biotechnology
Strong demand for insect-protected and herbicide-
tolerant crops
Recent shift towards products with enhanced output traits
iagnostic
Therapy selection and monitoring utili!ing
genetic data
"ndustrial Biotechnology
The pulp and paper industry
-
8/10/2019 Adi-Alon
9/20T M
Febtuary 2001
Glo*al Potential ! Biotech Is +njoyingGlo*al Potential ! Biotech Is +njoying
Increasing In#estors AttentionIncreasing In#estors Attention
ource 3A4A5, 6rice 7aterhouse Coopers
+ndex
ASA: 5iotec% 0ndex
);an 199< $ ;an '))1(
0
400
800
1200
1600
2000
-#
89:;;= -
?
89:;;= -
$
89:;;= -
@
89:;;= -
%
89:;;= -
-
89:;;= !
!
89:;;= !
&
89:;.
ommittees may also include pharmaceutical companies
and other interested parties (eg ompa. and #fi!er)
urc#asing8 4#e 6ounci% negotiates broad basedagreements /it# scientific supp%iers as a cost saving
mec#anism for its members
6onferences8 5oca% and internationa% conferences are
organi?ed on broad issues ,e-g- =I2000. or on a specific
topic ,e-g- financing.
-
8/10/2019 Adi-Alon
19/20
T M
Febtuary 2001
2rivate sector
leaders%i! %eadedby t%e 05 to 4or4it% government onim!lementingcluster initiative
+ppoint a fu%% time pro@ect %eader or executive director to %ead t#e imp%ementation effort
=ring biotec# on t#e nationa% agenda and dec%are a c%ear vision for t#e industry
Form an intergovernmenta% tas' force to coordinate government po%icy
U!grade !%ysicalinfrastructure 4%ic%su!!orts t%eindustry
+ttract an int% company and support Israe%i companies /#ic# offer integrated services
and e$uipment in pharmacology and animal testing
analytical services
G/# pilot batches manufacturing facility
Su!!ort a!!liedresearc% andtec%nology transfer!rocesses
Aor' /it# one university on a pi%ot p%an /#ic# inc%udes8
"ncrease financial and human resources to improve commerciali!ation activities
reate a pre-seed funding to support final development of innovations with
commercial potential to improve the odds of a successful technology transfer
Align "# and e.uity ownership rules of commerciali!ation companies in the
0niversities with incubators
Areas of Reco&&endations 4 Points Progra&Areas of Reco&&endations 4 Points Progra&
-
8/10/2019 Adi-Alon
20/20
T M
Febtuary 2001
Areas of Reco&&endations 4 Points Progra& 5cont1Areas of Reco&&endations 4 Points Progra& 5cont16
0m!rove earlycommerciali.ation $create 4orld classincubators dedicatedto t%e industry
&et up /or%d c%ass scientific and business advisory board to support incubator pro@ects
Increase funding and timing of pro@ects to meet industry needs
Imp%ement #ig#%y se%ective screening process for pro@ects
/einforce regulatoryinfrastructure
Increase communication /it# t#e industry ( c%arify guide%ines and information re$uirementsfor c%inica% tria%s
Faci%itate approva% of p#ase 1 c%inica% tria%s t#roug# eit#er a. stronger %in'ages /it# t#e F!+
,e-g- F!+ affi%iate office.) or b. by adding resources to t#e #ea%t# ministry
+dd resources to t#e institute of standardi?ation and contro% of p#armaceutica% specia%i?edin biotec#no%ogy for eva%uation and GM accreditation
Ma! infrastructurere"uired tosu!!ort researc%in academia
Map e$uipment re$uirements for academic researc# to ensure t#at Israe%s academia
maintains its position
4rac' data on industria% and researc# activity to faci%itate net/or'ing and monitorperformance
0m!lement tracingsystem for industrydata and!erformancematrix
